
PPBT
Healthcare · Biotechnology · $2.7M market cap
$1.63+0.07 (+4.5%)Nov 13, 4:00 PM EST
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Sep 30, 2026
EPS trend, 90 days to now · -585.7% over 90 days · 30-day revisions 0 up, 1 down
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 13, 2026 | Time not confirmed | -2.88 | — | — |
| Aug 7, 2026 | Before the open | -0.98 | 1.07 | +209.2% |
| May 19, 2026 | Before the open | -0.38 | -2.33 | -512.4% |
| Mar 13, 2026 | Before the open | -3.40 | -6.16 | -81.2% |
| Nov 14, 2025 | Before the open | -2.60 | 2.90 | +211.5% |
| Aug 6, 2025 | Before the open | -2.10 | -4.00 | -90.5% |
| May 21, 2025 | Before the open | — | -0.17 | — |
| Mar 10, 2025 | Before the open | -2.20 | -2.71 | -23.2% |
| Nov 15, 2024 | Before the open | -0.60 | -13.67 | -2178.3% |
| Aug 16, 2024 | Before the open | -26.00 | -15.88 | +38.9% |
| May 21, 2024 | Before the open | -30.00 | -30.26 | -0.9% |
| Mar 5, 2024 | Before the open | -34.00 | -63.14 | -85.7% |
| Nov 21, 2023 | Before the open | -44.00 |
Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug resistance for cancer patients in the United States. Its oncology pipeline includes CM24, a humanized monoclonal antibody that blocks the interactions of carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhibitors, which is in Phase 2…
| -42.02 |
| +4.5% |
| Aug 22, 2023 | Before the open | -50.00 | -44.22 | +11.6% |
| May 16, 2023 | After the close | -70.00 | -41.60 | +40.6% |
| Feb 8, 2023 | Before the open | -50.00 | -58.90 | -17.8% |
| Nov 8, 2022 | Before the open | -42.00 | -45.56 | -8.5% |
| Aug 4, 2022 | After the close | -0.20 | -0.20 | 0.0% |
| May 12, 2022 | After the close | — | -0.41 | — |
| Mar 8, 2022 | After the close | -2.00 | -0.25 | +87.5% |
| Dec 1, 2021 | Time not confirmed | -0.01 | -0.17 | -1600.0% |
| Aug 5, 2021 | After the close | -0.01 | 0.00 | +100.0% |
| Jun 10, 2021 | Before the open | -2.00 | -76.00 | -3700.0% |
| Mar 2, 2021 | After the close | -0.01 | -0.01 | 0.0% |
| Dec 2, 2020 | Time not confirmed | -0.01 | -0.01 | 0.0% |
| Aug 11, 2020 | After the close | -0.10 | -0.01 | +90.0% |
| Jun 3, 2020 | Time not confirmed | — | -0.04 | — |
| Feb 11, 2020 | After the close | -0.09 | -0.30 | -233.3% |
| Nov 27, 2019 | Time not confirmed | -0.13 | 0.00 | +100.0% |
| Aug 8, 2019 | After the close | -0.60 | 0.00 | +100.0% |
| May 29, 2019 | Time not confirmed | -0.19 | -0.19 | 0.0% |
| Mar 25, 2019 | After the close | -20.00 | -30.00 | -50.0% |
| Nov 28, 2018 | Time not confirmed | -0.01 | 0.00 | +100.0% |
| Aug 29, 2018 | After the close | -0.10 | -0.01 | +90.0% |
| May 5, 2018 | After the close | -0.10 | -0.10 | 0.0% |
| Mar 5, 2018 | Before the open | -20.00 | -30.00 | -50.0% |